WMSA
JAZZ icon

Weiss Multi-Strategy Advisers’s Jazz Pharmaceuticals JAZZ Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-5,000
Closed -$693K – 825
2014
Q1 		$693K Buy
+5,000
New +$753K 0.01% 564

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Weiss Multi-Strategy Advisers's JAZZ Position: Q4 2023 in Review

Weiss Multi-Strategy Advisers sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2023, closing a stake of 24,319 shares — an estimated $3.15M sold.

Weiss Multi-Strategy Advisers first reported a position in JAZZ in Q1 2022 and held it in 7 quarters. The position peaked at $5.03M in Q1 2023. 499 funds tracked by Wall St. Rank hold JAZZ as of Q4 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Jazz Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 24,319 Jazz Pharmaceuticals shares in Q4 2023, an estimated $3.15M.
  • Weiss Multi-Strategy Advisers first reported a position in Jazz Pharmaceuticals in Q1 2022 and held it in 7 quarters.
  • Weiss Multi-Strategy Advisers's Jazz Pharmaceuticals position peaked at $5.03M in Q1 2023.
  • 499 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.